For Healthcare Professionals

bIosimilar of aDalimumab, an European evAluation


About the study

The study objective is aimed to describe all country, site, investigator and patient variables that lead to treatment persistence for at least 12 months among patients with rheumatologic and intestinal chronic inflammatory diseases who were switched to FK adalimumab, in order to develop a model to predict persistence at 12 months.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


  1. Age ≥18 years, male or female.
  2. Patients diagnosed with one chronic inflammatory rheumatological (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis) or chronic inflammatory bowel (Crohn's disease, ulcerative colitis) diseases.
  3. Patients who have been switched to FK adalimumab from the reference product (Humira®) or another adalimumab biosimilar.
  4. Patients who have been prescribed FK adalimumab according to the SmPC prior to the inclusion.
  5. Patients able to understand and complete the study questionnaires in local language during the study visits.
  6. Patients willing to sign informed consent to meet data protection requirements


  1. Unwillingness to provide written informed consent.
  2. Patients participating or expected to participate in any randomised clinical trial during their treatment with FK adalimumab.
  3. Patients not expected to be available for study visits during 12 months.
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details


Ankylosing Spondylitis,Crohn Disease,Psoriatic Arthritis,Rheumatoid Arthritis,Ulcerative Colitis



Participants needed


Est. Completion Date

Apr 2024

Treatment type



Fresenius Kabi identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.